Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Mebiopharm Co., Ltd.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Mebiopharm Co., Ltd
ClinicalTrials.gov Identifier:
NCT00964080
First received: August 17, 2009
Last updated: April 26, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)